Webinars

Transformative Nutritional Strategies for Managing Crohn’s Disease

Presenter(s): David Suskind, MD

Date: 13 August 2025

Time: Noon-1 PM ET

Location: Virtual webinar

Continuing Education Credits: Nurse Contact 1.0; Dietitian 1.0 CPEU*

*The CPE activity application for the webinar Transformative Nutritional Strategies for Managing Crohn’s Disease is pending CDR review and approval for 1.0 CPEUs.

Join us for a webinar on Wednesday, 13 August, where David Suskind, MD, will evaluate the efficacy and clinical outcomes of dietary therapies for IBD management, develop practical strategies for implementing EEN to help induce remission in Crohn’s disease, and apply patient-centered approaches to nutritional management of IBD.

This webinar will address the following learning objectives:

  • Evaluate the clinical efficacy of nutritional therapies in Inflammatory Bowel Disease (IBD).
  • Discuss the role of Exclusive Enteral Nutrition (EEN) in inducing remission in Crohn’s disease.
  • Interpret the impact of nutritional interventions on inflammatory markers and clinical outcomes.
  • Identify barriers and strategies for implementing nutritional therapy in clinical practice.
  • Apply patient-centered approaches to nutritional management of IBD.
Register
Event Flyer

Transformative Nutritional Strategies for Managing Crohn’s Disease

Download Flyer (PDF 0.41 MB)

Presenter Bio(s):

David L Suskind, MD

Professor of Pediatrics
Division of Gastroenterology
Seattle Children's Hospital
University of Washington
Seattle, WA, USA

Dr David L Suskind is a pediatric gastroenterologist and professor of pediatrics at the University of Washington School of Medicine, serving as the Director of Quality Assurance and Improvement as well as ImproveCareNow Physician Lead at Seattle Children’s Hospital. He is a recognized leader in the field of inflammatory bowel disease (IBD), particularly in integrating dietary therapies into clinical care. Dr Suskind’s research has demonstrated that the Specific Carbohydrate Diet (SCD) can induce clinical and biochemical remission in pediatric patients with active Crohn’s disease and ulcerative colitis. His studies also explore how dietary interventions influence the fecal microbiome, aiming to personalize treatment approaches. As a founder of NiMBAL (Nutrition in IBD and Lifestyle), Dr Suskind advocates for patient and family empowerment through education and evidence-based dietary strategies. His ongoing commitment to advancing pediatric gastroenterology has made a significant impact on both clinical practice and patient quality of life.

Category
CE CPEU Pediatric Gastrointestinal